New respiratory drugs Nucala (mepolizumab) for severe asthma and Advair follow-up Trelegy (fluticasone furoate, umeclidinium, and vilanterol) made a solid supporting cast in the three-month period.

An Advance Beneficiary Notice of Noncoverage (ABN) lets you know when Medicare may not cover an item or service. If a claim has been denied for Medicare coverage, you can appeal. Sometimes ...

Elon Musk, the world’s richest man and the head of Donald Trump’s so-called Department of Government Efficiency (DOGE), wants massive cuts to America’s core safety-net programs. “Reports ...

Or look in the next section to learn how much you can save by using an Optum Perks coupon. Note ... you’ll pay for Breztri Aerosphere with Medicare, talk with your doctor, pharmacist, or ...

TBPH also had an economic interest in TRELEGY, a GSK drug that was then expected to generate global peak sales of $3.6 billion annually. From 2024 data: GSK posted Q4 2024 and FY 2024 global ...

The USA's Institute for Clinical and Economic Review (ICER) has published a special report on chronic obstructive pulmonary disease (COPD) therapies as part of the Centers for Medicare & Medicaid ...

Trelegy Ellipta and Breo Ellipta, two drugs selected to be part of the next set of drugs to be assessed under Medicare’s drug price negotiation program, offer the advantage of requiring only one puff ...

So far Trelegy has been launched in 30 countries and continues to roll out, with recent approvals in Japan and China setting up launches in those big markets later this year.